Manufacturer
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
Contents
Loratadine 5 mg, pseudoephedrine sulfate 120 mg
Indication
Allergic rhinitis and common cold.
Instruction
Extended-Release: May be taken with or without food. Swallow whole, do not break, chew or dissolve.
Drug interaction
Loratadine: Increased loratadine levels with ritonavir, amprenavir; increased loratadine levels with erythromycin, cimetidine and ketoconazole without evidence of clinical significance or toxicity; may block effects of betahistine. Pseudoephedrine: Increased adverse effects (e.g. somnolence, agitation) with atomoxetine; increased BP or heart rate with sibutramine.Potentially Fatal: Pseudoephedrine: Increased risk of psychosis with bromocriptine; increased risk of fatal hypertensive crisis with MAOI, avoid concurrent use during and for 2 wk after stopping the MAOI; increased BP with linezolid and selegiline.
Malaysia
